Hostname: page-component-74656f9884-6grmk Total loading time: 0 Render date: 2026-11-05T22:28:20.043Z Has data issue: false hasContentIssue false

Health-related quality of life and enrollment in Phase 1 trials in children with incurable cancer

Published online by Cambridge University Press:  03 March 2006

MARU BARRERA
Affiliation:
Department of Psychology, Haematology/Oncology Program, Population Health Sciences, Research Institute, The Hospital for Sick Children, and University of Toronto, Toronto, Ontario, Canada
NORMA D'AGOSTINO
Affiliation:
Department of Psychosocial Oncology, Palliative Care, After Care and Survivorship Program, Princess Margaret Hospital, Toronto, Canada
JANET GAMMON
Affiliation:
Haemotology/Oncology Division, The Hospital for Sick Children, Toronto, Ontario, Canada
LYNLEE SPENCER
Affiliation:
Department of Psychology, Haematology/Oncology Program, The Hospital for Sick Children, Toronto, Ontario, Canada
SYLVAIN BARUCHEL
Affiliation:
Haemotology/Oncology Division, The Hospital for Sick Children, Toronto, Ontario, Canada
Rights & Permissions [Opens in a new window]

Abstract

Objectives: To investigate health-related quality of life (HRQOL) in children eligible for Phase 1 trials and the reasons why families consider participating in these trials.

Methods: Individual, semistructured interviews were conducted with parents (seven mothers, two fathers) and three children, after a child was invited to participate in a clinical trial. Information regarding disease and treatment progression, daily life, and decision making about experimental treatments was elicited. Interviews were recorded, transcribed, and coded for themes.

Results: HRQOL themes were grouped into four main domains: physical, psychological, social, and spiritual. Minimal physical restrictions, maintaining normalcy and control, information sharing, and having hope for life seemed to be critical HRQOL components. Hope for a cure and prolonging the child's life were the main reasons for enrolling in Phase 1 trials.

Conclusions: Normalcy and control are key end-of-life HRQOL components, and hope for life is a main reason for participating in Phase 1 trials.

Information

Type
Research Article
Copyright
© 2005 Cambridge University Press